KUALA LUMPUR (Dec 29): Duopharma Biotech Bhd said the government has extended the agreement for the supply and delivery of human insulin products by one year, from Dec 2, 2020 to Dec 1, 2021, with an additional contract value of RM19.625 million. In a filing with Bursa Malaysia today, Duopharma Biotech said...
Read Full StoryTop News
Related
DISEASE PREVENTION AND TREATMENT
Florida Vaccine Updates: CVS Openings Remain, Broward Health Offers Doses to High Risk Patients
, 5min
0
DISEASE PREVENTION AND TREATMENT
Tennessee restrictions on visitation at long-term care facilities lifted on Sunday
, 5min
0